U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Facial telangiectasia

MedGen UID:
488948
Concept ID:
C0858684
Finding
Synonyms: Facial telangiectatic vessels; Telangiectasia, facial
 
HPO: HP:0007380

Definition

Telangiectases (small dilated blood vessels) located near the surface of the skin of the face. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVFacial telangiectasia

Conditions with this feature

Telangiectasia, hereditary hemorrhagic, type 2
MedGen UID:
324960
Concept ID:
C1838163
Disease or Syndrome
Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.
H syndrome
MedGen UID:
400532
Concept ID:
C1864445
Disease or Syndrome
The histiocytosis-lymphadenopathy plus syndrome comprises features of 4 histiocytic disorders previously thought to be distinct: Faisalabad histiocytosis (FHC), sinus histiocytosis with massive lymphadenopathy (SHML), H syndrome, and pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome (PHID). FHC was described as an autosomal recessive disease involving joint deformities, sensorineural hearing loss, and subsequent development of generalized lymphadenopathy and swellings in the eyelids that contain histiocytes (summary by Morgan et al., 2010). SHML, or familial Rosai-Dorfman disease, was described as a rare cause of lymph node enlargement in children, consisting of chronic massive enlargement of cervical lymph nodes frequently accompanied by fever, leukocytosis, elevated erythrocyte sedimentation rate, and polyclonal hypergammaglobulinemia. Extranodal sites were involved in approximately 25% of patients, including salivary glands, orbit, eyelid, spleen, and testes. The involvement of retropharyngeal lymphoid tissue sometimes caused snoring and sleep apnea (summary by Kismet et al., 2005). H syndrome was characterized by cutaneous hyperpigmentation and hypertrichosis, hepatosplenomegaly, heart anomalies, and hypogonadism; hearing loss was also found in about half of patients, and many had short stature. PHID was characterized by predominantly antibody-negative insulin-dependent diabetes mellitus associated with pigmented hypertrichosis and variable occurrence of other features of H syndrome, with hepatosplenomegaly occurring in about half of patients (Cliffe et al., 2009). Bolze et al. (2012) noted that mutations in the SLC29A3 gene (612373) had been implicated in H syndrome, PHID, FHC, and SHML, and that some patients presented a combination of features from 2 or more of these syndromes, leading to the suggestion that these phenotypes should be grouped together as 'SLC29A3 disorder.' Bolze et al. (2012) suggested that the histologic features of the lesions seemed to be the most uniform phenotype in these patients. In addition, the immunophenotype of infiltrating cells in H syndrome patients was shown to be the same as that seen in patients with the familial form of Rosai-Dorfman disease, further supporting the relationship between these disorders (Avitan-Hersh et al., 2011; Colmenero et al., 2012).
Rombo syndrome
MedGen UID:
356704
Concept ID:
C1867147
Disease or Syndrome
Rombo syndrome has characteristics of vermiculate atrophoderma, milia, hypotrichosis, trichoepitheliomas, and peripheral vasodilation with cyanosis and basal cell carcinomas. It has been described in four generations of one family and in two additional sporadic cases. The skin lesions become visible between 7 and 10 years of age and are most pronounced on the face. Basal cell carcinomas are frequent and develop at around 35 years of age.
Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome
MedGen UID:
482833
Concept ID:
C3281203
Neoplastic Process
Patients with this syndrome develop cutaneous telangiectases in infancy with patchy alopecia over areas of affected skin, thinning of the lateral eyebrows, and mild dental and nail anomalies. Affected individuals are at increased risk of developing oropharyngeal cancer, and other malignancies have been reported as well (Tanaka et al., 2012).
Pontocerebellar hypoplasia type 2E
MedGen UID:
862925
Concept ID:
C4014488
Disease or Syndrome
Pontocerebellar hypoplasia type 2E is an autosomal recessive neurodegenerative disorder characterized by profound mental retardation, progressive microcephaly, spasticity, and early-onset epilepsy (summary by Feinstein et al., 2014). For a general phenotypic description and a discussion of genetic heterogeneity of pontocerebellar hypoplasia type 2, see PCH2A (277470).
Developmental delay, language impairment, and ocular abnormalities
MedGen UID:
1824035
Concept ID:
C5774262
Disease or Syndrome
Developmental delay, language impairment, and ocular abnormalities (DEVLO) is characterized by delayed acquisition of skills particularly affecting speech and language development, although many patients show mild motor delay. Most affected individuals also have a small head circumference (down to -3 SD) and may have mild dysmorphic features. Variable ocular anomalies include strabismus, cataracts, and cortical visual impairment. Older patients require special schooling and often demonstrate behavioral abnormalities (Laboy Cintron et al., 2022).
Neurodevelopmental disorder with microcephaly and movement abnormalities
MedGen UID:
1841260
Concept ID:
C5830624
Disease or Syndrome
Neurodevelopmental disorder with microcephaly and movement abnormalities (NEDMIM) is an autosomal recessive disorder characterized by global developmental delay, impaired intellectual development with poor or absent speech, and delayed walking with an abnormal gait. Affected individuals may show hypotonia or hypertonia with spasticity, ataxia, and choreoathetoid movements. Most patients have microcephaly and short stature. Ophthalmic features, behavioral abnormalities, and nonspecific dysmorphic features are commonly observed. Additional more variable features include seizures, brain imaging abnormalities, and skeletal defects (Serey-Gaut et al., 2023).

Professional guidelines

PubMed

Smit JM, Bauland CG, Wijnberg DS, Spauwen PH
Br J Plast Surg 2005 Oct;58(7):981-7. doi: 10.1016/j.bjps.2005.04.057. PMID: 16039628
Goldman MP
Am J Clin Dermatol 2004;5(6):423-34. doi: 10.2165/00128071-200405060-00007. PMID: 15663339
Goldman MP, Weiss RA, Brody HJ, Coleman WP 3rd, Fitzpatrick RE
J Dermatol Surg Oncol 1993 Oct;19(10):899-906; quiz 909-10. doi: 10.1111/j.1524-4725.1993.tb00976.x. PMID: 8408908

Recent clinical studies

Etiology

Gao L, Qu H, Gao N, Li K, Dang E, Tan W, Wang G
J Cosmet Dermatol 2020 Jan;19(1):88-92. Epub 2019 Oct 22 doi: 10.1111/jocd.13179. PMID: 31638320
Mekić S, Hamer MA, Wigmann C, Gunn DA, Kayser M, Jacobs LC, Schikowski T, Nijsten T, Pardo LM
J Eur Acad Dermatol Venereol 2020 Apr;34(4):821-826. Epub 2019 Nov 25 doi: 10.1111/jdv.15996. PMID: 31593313
Greveling K, Prens EP, Liu L, van Doorn MBA
J Eur Acad Dermatol Venereol 2017 Jul;31(7):1096-1110. Epub 2017 Feb 8 doi: 10.1111/jdv.14130. PMID: 28107576
Chinem VP, Miot HA
An Bras Dermatol 2011 Mar-Apr;86(2):292-305. doi: 10.1590/s0365-05962011000200013. PMID: 21603813
Goldman MP, Weiss RA, Brody HJ, Coleman WP 3rd, Fitzpatrick RE
J Dermatol Surg Oncol 1993 Oct;19(10):899-906; quiz 909-10. doi: 10.1111/j.1524-4725.1993.tb00976.x. PMID: 8408908

Diagnosis

Dong R, Jin Q, Zhi J, Luo Y, Yuan J, Pi L, Nan M, Jin Z, Jin C
J Cosmet Dermatol 2023 Jun;22(6):1835-1843. Epub 2023 Jan 31 doi: 10.1111/jocd.15645. PMID: 36718821
Aksoy Sarac G, Onder M
J Cosmet Dermatol 2022 Mar;21(3):1018-1022. Epub 2021 Apr 28 doi: 10.1111/jocd.14162. PMID: 33872451
Wollina U, Goldman A
Dermatol Ther 2020 Jul;33(4):e13558. Epub 2020 May 25 doi: 10.1111/dth.13558. PMID: 32390286
Kasumagic-Halilovic E, Hasic M, Ovcina-Kurtovic N
Med Arch 2019 Dec;73(6):394-398. doi: 10.5455/medarh.2019.73.394-398. PMID: 32082007Free PMC Article
Chinem VP, Miot HA
An Bras Dermatol 2011 Mar-Apr;86(2):292-305. doi: 10.1590/s0365-05962011000200013. PMID: 21603813

Therapy

Victor Ross E, Chodkiewicz H, Javvaji S, Zumwalt J, Kutscher TD, Tran C
Lasers Surg Med 2021 Jan;53(1):109-114. Epub 2020 Aug 10 doi: 10.1002/lsm.23309. PMID: 32779273
Turkmen D, Altunisik N, Sener S
Lasers Med Sci 2021 Mar;36(2):401-406. Epub 2020 Jun 26 doi: 10.1007/s10103-020-03082-3. PMID: 32592131
Mohammed EM, Makki MA, Solyman ZS, Elsaie ML
J Cosmet Dermatol 2020 Sep;19(9):2313-2316. Epub 2020 Jul 8 doi: 10.1111/jocd.13562. PMID: 32564519
Gao L, Qu H, Gao N, Li K, Dang E, Tan W, Wang G
J Cosmet Dermatol 2020 Jan;19(1):88-92. Epub 2019 Oct 22 doi: 10.1111/jocd.13179. PMID: 31638320
Greveling K, Prens EP, Liu L, van Doorn MBA
J Eur Acad Dermatol Venereol 2017 Jul;31(7):1096-1110. Epub 2017 Feb 8 doi: 10.1111/jdv.14130. PMID: 28107576

Prognosis

Dong R, Jin Q, Zhi J, Luo Y, Yuan J, Pi L, Nan M, Jin Z, Jin C
J Cosmet Dermatol 2023 Jun;22(6):1835-1843. Epub 2023 Jan 31 doi: 10.1111/jocd.15645. PMID: 36718821
Mohamed EM, Mohamed Tawfik K, Hassan Ahmad W
J Cosmet Dermatol 2019 Dec;18(6):1675-1679. Epub 2019 Apr 29 doi: 10.1111/jocd.12963. PMID: 31033204
Prey S, Ezzedine K, Mazereeuw-Hautier J, Eschard C, Barbarot S, Boralevi F, Taïeb A, Léaute-Labrèze C; Groupe de Recherche Clinique en Dermatologie Pédiatrique
Pediatr Dermatol 2013 Jul-Aug;30(4):429-32. Epub 2013 Apr 8 doi: 10.1111/pde.12137. PMID: 23560522
Ozyurt K, Colgecen E, Baykan H, Ozturk P, Ozkose M
ScientificWorldJournal 2012;2012:197139. Epub 2012 Sep 17 doi: 10.1100/2012/197139. PMID: 23028248Free PMC Article
Chinem VP, Miot HA
An Bras Dermatol 2011 Mar-Apr;86(2):292-305. doi: 10.1590/s0365-05962011000200013. PMID: 21603813

Clinical prediction guides

Victor Ross E, Chodkiewicz H, Javvaji S, Zumwalt J, Kutscher TD, Tran C
Lasers Surg Med 2021 Jan;53(1):109-114. Epub 2020 Aug 10 doi: 10.1002/lsm.23309. PMID: 32779273
Gao L, Qu H, Gao N, Li K, Dang E, Tan W, Wang G
J Cosmet Dermatol 2020 Jan;19(1):88-92. Epub 2019 Oct 22 doi: 10.1111/jocd.13179. PMID: 31638320
Kapicioglu Y, Sarac G, Cenk H
Lasers Med Sci 2019 Feb;34(1):93-98. Epub 2018 Aug 10 doi: 10.1007/s10103-018-2606-6. PMID: 30097757
Gao L, Gao N, Song W, Dang E, Yin R, Wang L, Wang G
J Drugs Dermatol 2017 Nov 1;16(11):1112-1116. PMID: 29141059
Tanghetti EA
Lasers Surg Med 2012 Feb;44(2):97-102. Epub 2011 Dec 16 doi: 10.1002/lsm.21151. PMID: 22180317

Recent systematic reviews

Greveling K, Prens EP, Liu L, van Doorn MBA
J Eur Acad Dermatol Venereol 2017 Jul;31(7):1096-1110. Epub 2017 Feb 8 doi: 10.1111/jdv.14130. PMID: 28107576

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...